ENCOMPASS HEALTH DEACONESS REHABILIT — History
CCN 153025 | 3-year financial timeline | COVID resilience: 59/100
🛡️ Public data only — no PHI permitted on this instance.
$50M
Latest Revenue (FY2022)
+6.3%
Revenue CAGR (3yr)
29.7%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $44M | $51M | $50M | -2.3% | +6.3% |
| Operating Expenses | $32M | $35M | $35M | +1.1% | +5.8% |
| Operating Margin | 29.0% | 32.1% | 29.7% | -7.5% | +1.2% |
| Net Income | $13M | $17M | $15M | -9.7% | +7.6% |
| Licensed Beds | 98 | 98 | 98 | +0.0% | +0.0% |
| Total Patient Days | 30,694 | 33,409 | 31,174 | -6.7% | +0.8% |
| Medicare Day % | 66% | 58% | 56% | -4.0% | -7.8% |
| Medicaid Day % | 1% | 1% | 1% | -46.0% | -21.4% |
COVID Impact & Recovery
Resilience Score: 59/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +13.0% ($44M → $50M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+6.3%
This Hospital
+7.6%
State Avg
Latest Margin
29.7%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $53M | 30.1% |
| FY2024 (proj) | $56M | 30.4% |
| FY2025 (proj) | $59M | 30.8% |